Antengene Corporation,Antengene Antengene Corporation,Antengene
  • Home
  • About Us
    About Antengene Management Team Board Of Directors Scientific Advisory Board Antengene Events Investors Company honor Contact Us
  • Our Business
    Discovery Development Manufacturing Commercialization Pipeline
  • Our Products
  • Newsroom
  • Partnerships
    Partnering with Antengene Partnership
  • Investor Relations
    Announcements & Circulars Corporate Governance Financial Report Webcast & Presentation Event Calendar Investor Contact
  • Career
    Social Responsibility Working at Antengene Join Us
简 EN

Company News

Media Report

Year Select
All
  1. All
  • 2021
    03
    02
    01
  • 2020
    12
    11
    10
    09
    08
    07
    06
    05
    04
    03
    02
    01
  • 2019
    12
    10
    09
    07
    04
    02
    01
  • 2018
    12
    09
    08
    07
    06
    05
    03
    02
  • 2017
    11
    09
    08
    04
  1. Apr 06, 2022

    Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study

  2. Mar 10, 2022

    Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting

  3. Mar 02, 2022

    Antengene Announces XPOVIO® Regulatory Approval in Singapore for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Three Indications

  4. Feb 07, 2022

    Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037

  5. Dec 30, 2021

    Antengene Announces First Patient Dosed in REACH Study of ATG-016 for the Treatment of Advanced Solid Tumors

  6. Jun 09, 2021

    Founder and CEO of Antengene, Dr. Jay Mei, talks innovation in biotech, passion and learning from our mistakes

  • Home
  • About us
  • Our Business
  • Newsroom
  • Partnerships
  • investor Relations
  • career

Copyright © 2020 By Antengene Corporation. All Rights Reserved sitemap sitemap

  • About Us
    About Us Management Team Board Of Directors Scientific Advisory Board antengene events Investors Company honor Contact Us
  • Our Business
    Discovery Development Manufacturing Commercialization Pipeline
  • Newsroom
  • Partnerships
    Partnering with Antengene Partnership
  • Investor Relations
    Announcements & Circulars Corporate Governance Financial Report Corporate Presentation Event Calendar Investor Contact
  • Career
    Social Responsibility Working at Antengene Join Us